Abstract
Purpose
Methods and Materials
Results
Conclusions
Introduction
Methods and Materials
Mouse models and care
Mouse irradiation

Irradiation machine and setup
Approach to the analysis of ovarian toxicity
Approach to the analysis of testicular toxicity
Tissue preparation and histology
Histopathologic analyses
Ovarian toxicity
Testicular toxicity
Immunostaining
Statistical analysis
Results
8-Gy UHDR-RT delivered in a single pulse induces similar acute ovarian toxicity as CONV-RT

16-Gy UHDR-RT delivered in multiple pulses induces similar acute ovarian toxicity as CONV-RT

5-Gy UHDR-RT delivered in a single pulse induces similar acute testicular toxicity as CONV-RT

Discussion
Conclusion
Acknowledgments
Appendix. Supplementary materials
References
- Mechanisms of normal tissue injury from irradiation.Semin Radiat Oncol. 2017; 27: 316-324
- Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation.Int J Radiat Biol. 2022; 98: 506-516
- FLASH radiotherapy: Current knowledge and future insights using proton-beam therapy.Int J Mol Sci. 2020; 21: 6492
- Radiobiology of the FLASH effect.Med Phys. 2022; 49: 1993-2013
- Review of conventional and high dose rate brain radiation (FLASH): Neurobehavioural, neurocognitive and assessment issues in rodent models.Clin Oncol. 2021; 33: e482-e491
- Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice.Sci Transl Med. 2014; 6: 245ra93
- Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation.Radiother Oncol. 2019; 139: 4-10
- FLASH irradiation spares lung progenitor cells and limits the incidence of radio-induced senescence.Clin Cancer Res. 2020; 26: 1497-1506
- FLASH irradiation results in reduced severe skin toxicity compared to conventional-dose-rate irradiation.Radiat Res. 2020; 194: 618-624
- FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response.Cancer Res. 2021; 81: 4808-4821
- FLASH proton pencil beam scanning irradiation minimizes radiation-induced leg contracture and skin toxicity in mice.Cancers. 2021; 13: 1012
- The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients.Clin Cancer Res. 2019; 25: 35-42
- Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice.Sci Rep. 2020; 10: 1-14
- Irradiation at ultra-high (FLASH) dose rates reduces acute normal tissue toxicity in the mouse gastrointestinal system.Int J Radiat Oncol Biol Phys. 2021; 111: 1250-1261
- Ultra-high-dose-rate FLASH and conventional-dose-rate irradiation differentially affect human acute lymphoblastic leukemia and normal hematopoiesis.Int J Radiat Oncol Biol Phys. 2021; 109: 819-829
- Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome.Sci Rep. 2019; 9: 17180
- Dose- and volume-limiting late toxicity of FLASH radiotherapy in cats with squamous cell carcinoma of the nasal planum and in mini pigs.Clin Cancer Res. 2022; 28: 3814-3823
- Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.Radiother Oncol. 2022; 174: 87-91
- Feasibility of proton FLASH effect tested by zebrafish embryo irradiation.Radiother Oncol. 2019; 139: 46-50
- Evaluating very high energy electron RBE from nanodosimetric pBR322 plasmid DNA damage.Sci Rep. 2021; 11: 3341
Perstin A, Poirier Y, Sawant A, Tambasco M. Physics contribution quantifying the DNA-damaging effects of FLASH irradiation with plasmid DNA. 2022;113:437-447.
- Ultra-high dose rate electron beams and the FLASH effect: From preclinical evidence to a new radiotherapy paradigm.Med Phys. 2022; 49: 2082-2095
- Radiation-induced tissue damage and response.J Pathol. 2020; 250: 647-655
- Clinical radiation pathology as applied to curative radiotherapy.Cancer. 1968; 22: 767-778
- Pelvic radiation and normal tissue toxicity.Semin Radiat Oncol. 2017; 27: 358-369
- Gonadal failure after treatment of hematologic malignancies: From recognition to management for health-care providers.Nat Clin Pract Oncol. 2008; 5: 78-89
- Establishment of early endpoints in mouse total-body irradiation model.PLoS One. 2016; 11e0161079
- The effect of raloxifene on the uterine weight response in immature mice exposed to 17beta-estradiol, 1,1,1-trichloro-2, 2-bis(p-chlorophenyl)ethane, and methoxychlor.Am J Obstet Gynecol. 2000; 182: 1099-1102
- Continuous loss of oocytes throughout meiotic prophase in the normal mouse ovary.Dev Biol. 2003; 258: 334-348
- The current knowledge on radiosensitivity of ovarian follicle development stages.Hum Reprod Update. 2009; 15: 359-377
- The mammalian oocyte orchestrates the rate of ovarian follicular development.Proc Natl Acad Sci U S A. 2002; 99: 2890-2894
- The two classes of primordial follicles in the mouse ovary: Their development, physiological functions and implications for future research.Mol Hum Reprod. 2014; 20: 286-292
- Radiation effects on male fertility.Andrology. 2019; 7: 2-7
- Relation between x-ray sensivity and stages of the cell cycle in spermatogogonia of the mouse.Radiat Res. 1962; 17: 809-838
- Spermatogenesis and cycle of the seminiferous epithelium.Adv Exp Med Biol. 2008; 636: 1-15
- Nonproliferative and proliferative lesions of the rat and mouse female reproductive system.J Toxicol Pathol. 2014; 27: 1S-107S
- The female rat reproductive cycle: A practical histological guide to staging.Toxicol Pathol. 2008; 36: 375-384
- Proliferative and nonproliferative lesions of the rat and mouse male reproductive system.Toxicol Pathol. 2012; 40: 40S-121S
- Preservation of fertility in patients with cancer.N Engl J Med. 2009; 360: 902-911
- Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice.Clin Cancer Res. 2021; 27: 775-784
Article info
Publication history
Footnotes
Sources of support: This work was supported by grants R01CA108633, R01CA169368, RC2CA148190, and U10CA180850-01 (National Cancer Institute) and the Ohio State University Comprehensive Cancer Center (all to Dr Chakravarti). The histology and immunohistochemistry work was supported by the Comparative Pathology and Digital Imaging Shared Resource at the Ohio State University.
Disclosures: Dr Chakravarti reports a relationship with Varian Medical Systems that includes funding grants. Dr Blakaj reports a relationship with IntraOp Medical that includes funding grants. Dr Cetnar reports a relationship with the American Association of Physicists in Medicine that includes travel reimbursement and a board membership and serves as Associate Section Editor for Advances in Radiation Oncology. Dr McElroy reports a relationship with the Ohio State University Department of Radiation Oncology that includes employment and nonfinancial support. Dr Fleming serves as Associate Senior Editor for Advances in Radiation Oncology. Dr Ayan serves as Associate Section Editor for Advances in Radiation Oncology. No other disclosures were reported.
Research data are stored in an institutional repository and will be shared upon request to the corresponding author.
Identification
Copyright
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy